Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Shevrin

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Investigational New Drugs|July 1, 1989
Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council StudyD H Shevrin, T E Lad, L J Kilton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1988
Effects of cisplatin on parathyroid hormone- and human lung tumor-induced bone resorptionE C Abramson, J Chang, M Mayer, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center studyD H Shevrin, L J Kilton, T E Lad, et al.
The Journal of Clinical Investigation|November 1, 1988
Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumorsS C Kukreja, D H Shevrin, S A Wimbiscus, et al.
Cancer|December 1, 1985
A phase II study of Adriamycin in previously untreated squamous cell carcinoma of the head and neckM A Cobleigh, J H Hill, P A Gallagher, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 24, 1999
Assessment of coagulation system activation using spot urine measurementsS E Lind, S Goldshteyn, C P Barry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2025
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trialA Tripathi, Y Chen, D F Jarrard, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Investigational New Drugs|July 1, 1989
Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council StudyD H Shevrin, T E Lad, L J Kilton, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1988
Effects of cisplatin on parathyroid hormone- and human lung tumor-induced bone resorptionE C Abramson, J Chang, M Mayer, et al.
Investigational New Drugs|January 1, 1994
Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center studyD H Shevrin, L J Kilton, T E Lad, et al.
The Journal of Clinical Investigation|November 1, 1988
Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumorsS C Kukreja, D H Shevrin, S A Wimbiscus, et al.
Cancer|December 1, 1985
A phase II study of Adriamycin in previously untreated squamous cell carcinoma of the head and neckM A Cobleigh, J H Hill, P A Gallagher, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 24, 1999
Assessment of coagulation system activation using spot urine measurementsS E Lind, S Goldshteyn, C P Barry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2025
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trialA Tripathi, Y Chen, D F Jarrard, et al.
Pageof 3